Showing results (161-170 of 309) with videos related to
Sort By:
Pageof 31
Urology|November 17, 2001
A phase 3, multicenter, open-label, randomized study of abarelix versus leuprolide acetate in men with prostate cancerD McLeod, N Zinner, K Tomera, et al.Radiology|September 1, 1991
CT and pathologic predictive features of residual mass histologic findings after chemotherapy for nonseminomatous germ cell tumors: can residual malignancy or teratoma be excluded?P C Stomper, L A Kalish, M B Garnick, et al.Blood|February 15, 1990
In vivo hematologic effects of recombinant human macrophage colony-stimulating factorT R Ulich, J del Castillo, L R Watson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
Stage I nonseminomatous germ cell testicular tumor: prediction of metastatic potential by primary histopathologyC Y Fung, L A Kalish, G L Brodsky, et al.AJR. American Journal of Roentgenology|April 1, 1986
CT evaluation of advanced seminoma treated with chemotherapyP C Stomper, M S Jochelson, E L Friedman, et al.The Journal of Urology|August 1, 1978
Percutaneous nephrostomy: indications, complications and clinical usefulnessE Perinetti, W J Catalona, C B Manley, et al.Gene Therapy|June 14, 2000
Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer modelY Horiguchi, W A Larchian, R Kaplinsky, et al.Urological Research|January 1, 1990
Absence of structural alterations of the multidrug resistance genes in transitional cell carcinomaE A Klein, G Allen, W R Fair, et al.Cancer Research|June 15, 1992
Growth regulation of human renal carcinoma cells: role of transforming growth factor alphaI Atlas, J Mendelsohn, J Baselga, et al.The Journal of Urology|September 1, 1997
Ureteral carcinoma in situ at radical cystectomy: does the margin matter?D A Silver, N Stroumbakis, P Russo, et al.Pageof 31